HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of nimesulide on the growth of human laryngeal squamous cell carcinoma.

AbstractPURPOSE:
To investigate the effect of nimesulide on the growth of human laryngeal squamous cell carcinoma.
MATERIALS AND METHODS:
The effect of NIM on Hep-2 cell proliferation was measured by the MTT assay. Flow cytometry was used to evaluate the cell cycle and apoptosis in Hep-2 cells. A Western blot analysis was used to detect changes in the protein expression levels of COX-2, Survivin and proliferating cell nuclear antigen (PCNA) in Hep-2 cells. A Hep-2 tumor xenograft model was established in nude mice to observe tumor growth. The changes in the xenograft tumors were observed after hematoxylin/eosin staining. The expression levels of COX-2, Survivin and PCNA proteins and mRNA were measured by immunohistochemical analysis and RT-PCR, respectively.
RESULTS:
NIM had time- and dose-dependent inhibitory effect on the proliferation of Hep-2 cells. NIM could prevent the progression of the cell cycle. After NIM treatment, COX-2, Survivin and PCNA protein levels were reduced in the Hep-2 cells. The volume and weight of the xenograft tumors in the NIM treatment group were significantly reduced. The NIM treatment group also exhibited significantly reduced expression levels of COX-2, Survivin and PCNA at both the protein and mRNA levels.
CONCLUSIONS:
Our results suggested that NIM has significant inhibitory effects on the growth of Hep-2 cells and xenograft tumors in nude mice. Selective COX-2 inhibitors could potentially become part of a comprehensive treatment for laryngeal squamous cell carcinoma. Additional research and development will provide new and broader prospects for the prevention and treatment of laryngeal squamous cell carcinoma.
AuthorsZhuoping Liang, Jinbo Liu, Leiji Li, Haiyang Wang, Chong Zhao, Liang Jiang, Gang Qin
JournalAmerican journal of otolaryngology (Am J Otolaryngol) 2014 Mar-Apr Vol. 35 Issue 2 Pg. 120-9 ISSN: 1532-818X [Electronic] United States
PMID24321753 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014.
Chemical References
  • Birc5 protein, mouse
  • Cyclooxygenase Inhibitors
  • Inhibitor of Apoptosis Proteins
  • Platelet Aggregation Inhibitors
  • Proliferating Cell Nuclear Antigen
  • RNA, Messenger
  • Repressor Proteins
  • Sulfonamides
  • Survivin
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • nimesulide
Topics
  • Animals
  • Apoptosis (drug effects)
  • Blotting, Western
  • Carcinoma, Squamous Cell (drug therapy, genetics, pathology)
  • Cell Cycle (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cyclooxygenase 2 (biosynthesis, genetics)
  • Cyclooxygenase Inhibitors (pharmacology)
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Immunohistochemistry
  • Inhibitor of Apoptosis Proteins (biosynthesis, genetics)
  • Laryngeal Neoplasms (drug therapy, genetics, pathology)
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Experimental (drug therapy, genetics, pathology)
  • Platelet Aggregation Inhibitors
  • Proliferating Cell Nuclear Antigen (biosynthesis, genetics)
  • RNA, Messenger (genetics)
  • Real-Time Polymerase Chain Reaction
  • Repressor Proteins (biosynthesis, genetics)
  • Sulfonamides (pharmacology)
  • Survivin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: